H.C. Wainwright Reiterates Buy Rating on Helus Pharma (HELP)

July 22, 2026 6:52 AM

H.C. Wainwright analyst Patrick R. Trucchio reiterated a Buy rating and $70.00 price target on Helus Pharma (NASDAQ: HELP).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found